[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Darp101 [@DarpResearch](/creator/twitter/DarpResearch) on x XXX followers Created: 2025-06-03 12:00:44 UTC Yesterday I guessed the Shorts have gone deeper short to manipulate the NervGen $NGENF stock price down as they were in trouble with the gap up open on news and way underwater on their positions. Just looked at overnight IB Broker reports; that appears to be the case. After the open it went from XXXXXXX shares not shorted to 600,000; the interest rate to borrow went up, and the amount of their total NGENF stock short went from XX% to XX% yesterday. That is a huge amount. A few weeks ago there were no shorts. My take is that the meeting today will indeed be watched by big pharma companies; we were the biggest medical news yesterday in terms of market potential. Now that they know that NVG-291 does reconnect spinal cord nerves in humans on the first attempt, and that it did that for lab animals, and that it also repaired MS, and Stroke in animals, and logically should work for Alzheimer's, they will be all over NervGen to try and partner on the bigger markets that NervGen has said they will partner on. So although, IMHO, the shorts pulled off an operation to get out, that will not last, and a news bonanza will be coming in future months about NVG-291 and NVG-300 XXX and its various market segments and deals. XXXXX engagements  **Related Topics** [fed rate](/topic/fed-rate) [stocks](/topic/stocks) [ib](/topic/ib) [positions](/topic/positions) [the open](/topic/the-open) [$ngenf](/topic/$ngenf) [the gap](/topic/the-gap) [Post Link](https://x.com/DarpResearch/status/1929870865698525413)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Darp101 @DarpResearch on x XXX followers
Created: 2025-06-03 12:00:44 UTC
Yesterday I guessed the Shorts have gone deeper short to manipulate the NervGen $NGENF stock price down as they were in trouble with the gap up open on news and way underwater on their positions. Just looked at overnight IB Broker reports; that appears to be the case. After the open it went from XXXXXXX shares not shorted to 600,000; the interest rate to borrow went up, and the amount of their total NGENF stock short went from XX% to XX% yesterday. That is a huge amount. A few weeks ago there were no shorts. My take is that the meeting today will indeed be watched by big pharma companies; we were the biggest medical news yesterday in terms of market potential. Now that they know that NVG-291 does reconnect spinal cord nerves in humans on the first attempt, and that it did that for lab animals, and that it also repaired MS, and Stroke in animals, and logically should work for Alzheimer's, they will be all over NervGen to try and partner on the bigger markets that NervGen has said they will partner on. So although, IMHO, the shorts pulled off an operation to get out, that will not last, and a news bonanza will be coming in future months about NVG-291 and NVG-300 XXX and its various market segments and deals.
XXXXX engagements
Related Topics fed rate stocks ib positions the open $ngenf the gap